|
MRNA
|
Moderna, Inc.
|
0.83%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
0.83%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.81%
|
US
|
NASDAQ
|
|
SYNH
|
Syneos Health, Inc.
|
0.80%
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
0.77%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.70%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.65%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
0.49%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.49%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.48%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.48%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
0.47%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.46%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.43%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.43%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.42%
|
US
|
NASDAQ
|